Sarah McLaughlin
@smpittid.bsky.social
Misleading conclusion that is not in accordance with the results of the reported RCT
✅ Just Accepted
🔗 https://bit.ly/4iBZ4Pl
✅ Just Accepted
🔗 https://bit.ly/4iBZ4Pl
December 9, 2025 at 9:54 PM
The Impact of Corticosteroid Therapy on West Nile Virus-Infected Patients: A Retrospective Cohort Study
✅ Just Accepted
🔗 https://bit.ly/4rG0XhS
✅ Just Accepted
🔗 https://bit.ly/4rG0XhS
The Impact of Corticosteroid Therapy on West Nile Virus-Infected Patients: A Retrospective Cohort Study
In a 2024 Israeli cohort of 150 hospitalized West Nile virus patients, early corticosteroid therapy was associated with increased hospital mortality, sugge
bit.ly
December 9, 2025 at 9:53 PM
Navigating Nomenclature in Patient Care: Taxonomy Considerations from the College of American Pathologists? Microbiology Committee
✅ Just Accepted
🔗 https://bit.ly/4pUGlB5
✅ Just Accepted
🔗 https://bit.ly/4pUGlB5
December 9, 2025 at 9:53 PM
December 3, 2025 at 1:21 AM
New viability assays for Acanthamoeba castellanii trophozoites and cysts allow rapid assessment of drug activity
✅ Just Accepted
🔗 https://bit.ly/44pEqfB
✅ Just Accepted
🔗 https://bit.ly/44pEqfB
December 3, 2025 at 1:18 AM
Using generative artificial intelligence to identify central line-associated bloodstream infections
✅ Just Accepted
🔗 https://bit.ly/3LZD70g
✅ Just Accepted
🔗 https://bit.ly/3LZD70g
November 23, 2025 at 5:46 PM
Neuroaxonal Injury in Acute HIV Infection and Following Immediate Antiretroviral Therapy
✅ Just Accepted
🔗 https://bit.ly/47ZC5du
✅ Just Accepted
🔗 https://bit.ly/47ZC5du
November 23, 2025 at 5:46 PM
Tuberculosis infection screening recommendations for targeted immunotherapies: comparison of U.S. prescribing information, clinical resources and quality measures
✅ Just Accepted
🔗 https://bit.ly/43K2IQZ
✅ Just Accepted
🔗 https://bit.ly/43K2IQZ
November 23, 2025 at 5:45 PM
International Collaboration to Develop and Harmonize Drug Interaction Guidance for Nirmatrelvir/Ritonavir During COVID-19: Lessons Learned for Future Pandemic Preparedness
✅ Just Accepted
🔗 https://bit.ly/43TxFlJ
✅ Just Accepted
🔗 https://bit.ly/43TxFlJ
November 10, 2025 at 4:09 PM
Gut microbiota predicts the risk of future COVID-19 hospitalization and mortality: insights from the population-based HELIUS Study
✅ Just Accepted
🔗 https://bit.ly/47Ag2IA
✅ Just Accepted
🔗 https://bit.ly/47Ag2IA
November 10, 2025 at 4:08 PM
Characteristics and anti-adhesion activity of chicken scFv antibodies against Helicobacter pylori HpaA
✅ Just Accepted
🔗 https://bit.ly/3JKv8U6
✅ Just Accepted
🔗 https://bit.ly/3JKv8U6
November 7, 2025 at 2:21 PM
Does oral antibiotic switching therapy show similar efficacy to intravenous administration for treating infective endocarditis?
✅ Just Accepted
🔗 https://bit.ly/3JNCW7x
✅ Just Accepted
🔗 https://bit.ly/3JNCW7x
November 7, 2025 at 2:20 PM
Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From a Phase 3 Randomized Clinical Trial (CANOPY)
#IDSky
#IDSky
Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19
We report an interim analysis of safety and efficacy of pemivibart in individuals with (cohort A) or without (cohort B) significant immunocompromise in the phase 3 CANOPY trial.
bit.ly
November 4, 2025 at 5:51 PM
The win ratio should be complemented by other win statistics to provide a comprehensive picture of relative and absolute treatment effects: the case study of the REPRIEVE trial
✅ Just Accepted
🔗 https://bit.ly/4oqSQE6
✅ Just Accepted
🔗 https://bit.ly/4oqSQE6
November 4, 2025 at 5:51 PM
C-reactive protein in TB meningitis: a viable biomarker for individualized care.
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3IXBkId
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3IXBkId
October 24, 2025 at 10:49 PM
Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024
#IDSky
#IDSky
Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024
The 2023–2024 influenza season included sustained elevated activity from December 2023 to February 2024 and continued activity through May 2024. Influenza A(H1N1), A(H3N2), and B viruses circulated during the season.
bit.ly
October 24, 2025 at 10:49 PM
Asymptomatic Tuberculosis in Children with Household Exposure to Mycobacterium tuberculosis
✅ Just Accepted
#IDSky
🔗 https://bit.ly/47csDBA
✅ Just Accepted
#IDSky
🔗 https://bit.ly/47csDBA
October 18, 2025 at 5:14 PM
Metagenomic Sequencing of Blood Culture Broth for Diagnosing Fastidious Endocarditis
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4qbRJcA
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4qbRJcA
October 18, 2025 at 5:14 PM
Autoantibodies against type I interferons are a prominent feature in SARS-CoV-2 fatal disease and hospitalization
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Autoantibodies against type I interferons are a prominent feature in SARS-CoV-2 fatal disease and hospitalization
Autoantibodies against type I interferons, MPO and ACE2 are associated with COVID-19 severity and poor outcomes, show increasing titers overtime, and corre
bit.ly
October 18, 2025 at 5:14 PM
Immune responses to BK virus in renal transplant recipients receiving IVIG treatment
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3J9gtBs
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3J9gtBs
October 18, 2025 at 5:13 PM
Severity of Clinical Presentation and Outcomes in Hospitalized Adult Patients with Influenza by Type and Subtype, United States?2017?2020
✅ Just Accepted
#IDSky
🔗 https://bit.ly/48FSdkL
✅ Just Accepted
#IDSky
🔗 https://bit.ly/48FSdkL
October 5, 2025 at 12:44 AM
Insights on recurrent and sequential Clostridioides difficile infections from genomic surveillance in Minnesota, USA, 2019-2021
✅ Just Accepted
#IDSky
🔗 https://bit.ly/46zgcB0
✅ Just Accepted
#IDSky
🔗 https://bit.ly/46zgcB0
October 5, 2025 at 12:44 AM
Investigating Azithromycin Activity Against ESBL-Producing Escherichia coli Under Physiologically Relevant Conditions
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3KAnbAM
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3KAnbAM
September 25, 2025 at 12:56 PM
Culture Clash: Dual-Pathogen Endocarditis and the Metagenomic Next Generation Sequencing Studies We Need
✅ Just Accepted
🔗 https://bit.ly/4nIDf1Q
✅ Just Accepted
🔗 https://bit.ly/4nIDf1Q
September 25, 2025 at 12:55 PM
Febrile temperature augments ring-stage Plasmodium falciparum adhesion to brain endothelial cells
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4glzg8Z
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4glzg8Z
September 18, 2025 at 6:59 PM